Nanjing Medical Company To Restructure Xinjiang Production and Construction Corps Pharmaceutical
This article was originally published in PharmAsia News
Executive Summary
Nanjing Medical Company has signed an agreement to take a controlling stake in Xinjiang Production and Construction Corps Pharmaceutical. Under the agreement, Nanjing Medical will introduce funds, talent, products, an innovative business model and a modern management model to the Xinjiang company. On its part, the Xinjiang company will incorporate its TCM business and ethnic medicine resources with Nanjing Medical's TCM brand, farming base and end-user market. With sales exceeding RMB 3 billion, Xinjiang Production is a key state-owned pharmaceutical distributor as well as a national medical reserve unit for disaster relief. Nanjing Medical's core revenue hit RMB 8.152 billion in the first half of 2008, with its external expansion model accounting for the rapid growth. (Click here for more - Chinese language)
|
Nanjing Medical Company has signed an agreement to take a controlling stake in Xinjiang Production and Construction Corps Pharmaceutical. Under the agreement, Nanjing Medical will introduce funds, talent, products, an innovative business model and a modern management model to the Xinjiang company. On its part, the Xinjiang company will incorporate its TCM business and ethnic medicine resources with Nanjing Medical's TCM brand, farming base and end-user market. With sales exceeding RMB 3 billion, Xinjiang Production is a key state-owned pharmaceutical distributor as well as a national medical reserve unit for disaster relief. Nanjing Medical's core revenue hit RMB 8.152 billion in the first half of 2008, with its external expansion model accounting for the rapid growth. (Click here for more - Chinese language) "Nanjing Medical Company Uses Share Control To Restructure Xinjiang Production And Construction Corps Pharmaceutical" - Shanghai Securities News (Shanghai) (12/2/08) |